
Feature|Articles|May 12, 2026
- May/June 2026
- Volume 42
- Issue 02
Chronic skin conditions linked to bullying, depression, and suicide risk in children, adolescents
Author(s)Morgan Ebert, Executive Editor
Fact checked by: Benjamin P. Saylor, Ron Panarotti
Chronic pediatric skin disorders cause significant stigma, bullying, depression, and suicide risk—conditions often underrecognized and undertreated by physicians.
Advertisement
Advertisement
Pediatric patients with chronic skin diseases—including acne, atopic dermatitis (AD), and psoriasis—face significant and frequently underappreciated risks to their mental health and social well-being, according to findings from several recent studies examining quality of life, stigmatization, and psychiatric comorbidities in this population.1-5
Related to this article

At AAP 2026, Peter Lio, MD, discussed distinguishing allergic and inflammatory skin conditions and when pediatricians should seek specialty care.

A joinpoint analysis of 1991 to 2021 YRBSS data found suicidal ideation among US high school students declined through 2009, then increased through 2021.

Oral icotrokinra sustained scalp, genital, and hand/foot psoriasis clearance through week 112 in ICONIC-TOTAL, with no new safety signals.

A 16-month-old with recurrent otitis media developed a spreading unilateral rash on her hip and thigh during antibiotic treatment. PCR testing confirmed herpes zoster, an uncommon diagnosis in young, vaccinated children.

Upadacitinib showed continued facial and body repigmentation in NSV through week 76, with numerically higher responses when combined with NB-UVB.

The approval is based on BRAVE-AA-PEDS, in which 42% of adolescents receiving baricitinib 4 mg achieved at least 80% scalp hair coverage at week 36 vs 5% with placebo.
Advertisement
Advertisement


